Bristol-Myers Squibb Co. (BMY) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $61.68 --0%
EPS Growth %: -33.1%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -33.1%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.85 billion.
Bristol-Myers Squibb Co. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Danaher (DHR) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
